|
|
|
Volumn 23, Issue 1 SUPPL. 2, 1996, Pages 51-54
|
|
Adjuvant therapy for early stage breast cancer
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
CYCLOPHOSPHAMIDE;
DOXORUBICIN;
FLUOROURACIL;
METHOTREXATE;
PACLITAXEL;
TAMOXIFEN;
BONE MARROW TRANSPLANTATION;
BREAST CANCER;
CANCER ADJUVANT THERAPY;
CANCER HORMONE THERAPY;
CANCER REGRESSION;
CANCER STAGING;
CANCER SURVIVAL;
CLINICAL TRIAL;
DRUG MEGADOSE;
EARLY CANCER;
FEMALE;
HUMAN;
LYMPH NODE METASTASIS;
METASTASIS;
PRIORITY JOURNAL;
REVIEW;
STEM CELL TRANSPLANTATION;
ADULT;
ANTINEOPLASTIC AGENTS, HORMONAL;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
BREAST NEOPLASMS;
BRIDGED COMPOUNDS;
CHEMOTHERAPY, ADJUVANT;
CLINICAL TRIALS;
DISEASE-FREE SURVIVAL;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
FORECASTING;
HUMANS;
LYMPHATIC METASTASIS;
NEOPLASM STAGING;
SURVIVAL RATE;
TAXOIDS;
|
|
EID: 0029928240
PISSN: 00937754
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (9)
|
|
References (0)
|
